Dubai to use DME for crude oil pricing

The Dubai Mercantile Exchange (DME), a joint venture between Tatweer, Nymex and the Oman Investment Fund, announced today that the government of Dubai will cease pricing its export crude oil sales off its current mechanism and instead utilise DME futures prices upon launch of the exchange on June 1.

Dubai joins Oman in using DME settlement prices for its crude oil pricing. Together, Dubai and Oman crude represents the current foundation for pricing the majority of the Middle East’s crude oil sales to the Far East.

The DME hopes that producer support of its Middle East sour crude oil benchmark will ensure that customers have access to an improved risk management tool and that producing nations can recognise fair market value for their crude oil.

The exchange will launch its Oman crude oil

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

CTRM systems 2024: market update and vendor landscape

A Chartis report on commodity trading and risk management systems that considers its different applications and addresses the market and vendor dynamics to determine the long-term and structural impacts of the overarching market evolution on the…

Chartis Energy50 2023

The latest iteration of Chartis' Energy50 2023 ranking and report considers the key issues in today’s energy space, and assesses the vendors operating within it

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here